$0.95 EPS Expected for Steris Plc (STE) This Quarter
Wall Street analysts predict that Steris Plc (NYSE:STE) will announce $0.95 earnings per share for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for Steris Plc’s earnings. The highest EPS estimate is $1.00 and the lowest is $0.92. Steris Plc posted earnings of $0.89 per share during the same quarter last year, which suggests a positive year-over-year growth rate of 6.7%. The firm is scheduled to issue its next earnings report on Wednesday, November 1st.
According to Zacks, analysts expect that Steris Plc will report full year earnings of $4.06 per share for the current year, with EPS estimates ranging from $4.05 to $4.10. For the next financial year, analysts forecast that the company will post earnings of $4.54 per share, with EPS estimates ranging from $4.52 to $4.57. Zacks’ earnings per share averages are a mean average based on a survey of research analysts that follow Steris Plc.
Steris Plc (NYSE:STE) last released its quarterly earnings data on Tuesday, August 8th. The medical equipment provider reported $0.85 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.80 by $0.05. The business had revenue of $608.00 million for the quarter, compared to analysts’ expectations of $597.66 million. Steris Plc had a return on equity of 11.39% and a net margin of 4.63%. Steris Plc’s quarterly revenue was down 4.8% on a year-over-year basis. During the same period in the previous year, the business posted $0.79 earnings per share.
Several research firms recently weighed in on STE. Raymond James Financial, Inc. lifted their price target on Steris Plc from $90.00 to $95.00 and gave the stock an “outperform” rating in a report on Wednesday, August 9th. BidaskClub cut Steris Plc from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Finally, Zacks Investment Research cut Steris Plc from a “buy” rating to a “hold” rating in a report on Tuesday, August 22nd. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $86.75.
Steris Plc (NYSE STE) traded down 0.56% during mid-day trading on Tuesday, hitting $90.51. The stock had a trading volume of 271,653 shares. Steris Plc has a one year low of $63.80 and a one year high of $91.18. The firm has a market capitalization of $7.71 billion, a price-to-earnings ratio of 64.74 and a beta of 1.29. The stock’s 50 day moving average price is $87.07 and its 200 day moving average price is $79.97.
The company also recently declared a quarterly dividend, which was paid on Thursday, September 28th. Investors of record on Tuesday, August 29th were issued a dividend of $0.31 per share. This is a boost from Steris Plc’s previous quarterly dividend of $0.28. This represents a $1.24 annualized dividend and a yield of 1.37%. The ex-dividend date of this dividend was Friday, August 25th. Steris Plc’s dividend payout ratio (DPR) is presently 88.57%.
In other Steris Plc news, Director Mohsen Sohi sold 2,744 shares of the firm’s stock in a transaction on Wednesday, August 9th. The stock was sold at an average price of $85.98, for a total transaction of $235,929.12. Following the transaction, the director now owns 21,816 shares in the company, valued at approximately $1,875,739.68. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the firm’s stock in a transaction on Wednesday, August 16th. The stock was sold at an average price of $85.69, for a total value of $856,900.00. Following the transaction, the chief executive officer now owns 83,270 shares in the company, valued at approximately $7,135,406.30. The disclosure for this sale can be found here. Over the last three months, insiders have sold 194,086 shares of company stock valued at $16,953,621. 2.55% of the stock is currently owned by insiders.
A number of institutional investors have recently bought and sold shares of the business. Intl Fcstone Inc. bought a new position in Steris Plc during the 2nd quarter worth $1,482,000. GWM Advisors LLC increased its stake in Steris Plc by 59.8% during the 2nd quarter. GWM Advisors LLC now owns 6,741 shares of the medical equipment provider’s stock worth $553,000 after acquiring an additional 2,522 shares during the period. Koch Industries Inc. bought a new position in Steris Plc during the 2nd quarter worth $1,089,000. Westwood Holdings Group Inc. increased its stake in Steris Plc by 25.9% during the 2nd quarter. Westwood Holdings Group Inc. now owns 603,196 shares of the medical equipment provider’s stock worth $49,233,000 after acquiring an additional 124,155 shares during the period. Finally, Ameritas Investment Partners Inc. increased its stake in Steris Plc by 1.5% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 25,416 shares of the medical equipment provider’s stock worth $2,071,000 after acquiring an additional 379 shares during the period. Hedge funds and other institutional investors own 93.33% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “$0.95 EPS Expected for Steris Plc (STE) This Quarter” was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece on another domain, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The legal version of this piece can be read at https://www.thecerbatgem.com/2017/10/09/0-95-eps-expected-for-steris-plc-ste-this-quarter.html.
Steris Plc Company Profile
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Stock Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related stocks with our FREE daily email newsletter.